F. C. Copp

486 total citations
21 papers, 316 citations indexed

About

F. C. Copp is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, F. C. Copp has authored 21 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 7 papers in Molecular Biology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in F. C. Copp's work include Synthesis and biological activity (4 papers), Neuroscience and Neuropharmacology Research (3 papers) and Pain Mechanisms and Treatments (2 papers). F. C. Copp is often cited by papers focused on Synthesis and biological activity (4 papers), Neuroscience and Neuropharmacology Research (3 papers) and Pain Mechanisms and Treatments (2 papers). F. C. Copp collaborates with scholars based in United Kingdom and United States. F. C. Copp's co-authors include A. F. GREEN, A.L.A. Boura, H. F. Hodson, A McCoubrey, W. G. Duncombe, S. R. M. Bushby, J.E. Tateson, Amy Randall, R.A. Maxwell and Robert B. Burrows and has published in prestigious journals such as Nature, Journal of Pharmacology and Experimental Therapeutics and Cellular and Molecular Life Sciences.

In The Last Decade

F. C. Copp

19 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. C. Copp United Kingdom	10	96	75	69	38	37	21	316
L. B. Cobbin Australia	10	174 1.8×	39 0.5×	102 1.5×	87 2.3×	37 1.0×	22	421
D. H. Kaump United States	10	79 0.8×	28 0.4×	59 0.9×	21 0.6×	24 0.6×	21	411
Long Jp United States	12	173 1.8×	37 0.5×	156 2.3×	32 0.8×	48 1.3×	49	373
Edward J. Walaszek United States	12	138 1.4×	41 0.5×	62 0.9×	19 0.5×	36 1.0×	52	376
Sharon Pan United States	12	66 0.7×	68 0.9×	53 0.8×	12 0.3×	23 0.6×	37	346
R.H. Connamacher United States	6	113 1.2×	31 0.4×	83 1.2×	14 0.4×	49 1.3×	9	297
M. E. Bierwagen United States	9	94 1.0×	20 0.3×	126 1.8×	30 0.8×	147 4.0×	16	367
Gary Pekoe United States	7	126 1.3×	23 0.3×	111 1.6×	18 0.5×	112 3.0×	11	420
J. R. PFISTER United States	10	204 2.1×	44 0.6×	93 1.3×	41 1.1×	99 2.7×	15	468
A. L. Bartlet United Kingdom	13	147 1.5×	23 0.3×	110 1.6×	10 0.3×	68 1.8×	33	372

Countries citing papers authored by F. C. Copp

Since Specialization

Citations

This map shows the geographic impact of F. C. Copp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. C. Copp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. C. Copp more than expected).

Fields of papers citing papers by F. C. Copp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. C. Copp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. C. Copp. The network helps show where F. C. Copp may publish in the future.

Co-authorship network of co-authors of F. C. Copp

This figure shows the co-authorship network connecting the top 25 collaborators of F. C. Copp. A scholar is included among the top collaborators of F. C. Copp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. C. Copp. F. C. Copp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Copp, F. C., et al.. (1985). A novel ring closure leading to 3,9-dihydroxyaporphines (3,9-dihydroxy-4H-dibenzo[de,g]quinolines). Part 2. Journal of the Chemical Society Perkin Transactions 1. 2455–2455. 2 indexed citations

Copp, F. C., et al.. (1984). 3-N-substituted-amino-1-[3-(trifluoromethyl)phenyl]-2-pyrazolines have enhanced activity against arachidonate 5-lipoxygenase and cyclooxygenase. Biochemical Pharmacology. 33(2). 339–340. 32 indexed citations

Copp, F. C., et al.. (1983). Synthesis of 5,6,6a,7,7a,12a-hexahydro-4H-benzo[d,e]benzothieno-[2,3-g]quinolines and of 8-phenyl-2,3,7,8,9,9a-hexahydro-1H-benzo[d,e] quinolines. Journal of the Chemical Society Perkin Transactions 1. 909–909. 2 indexed citations

Wastila, William B., F. C. Copp, Eric F. Walton, Charles H. Ellis, & R.A. Maxwell. (1981). Meobentine sulphate (bis[N-4-methoxybenzyl-N′N″-dimethylguanidine]sulphate): a new antidysrhythmic agent. Journal of Pharmacy and Pharmacology. 33(1). 594–596. 8 indexed citations

Copp, F. C., et al.. (1979). A novel ring closure leading to 3-hydroxyaporphines. Journal of the Chemical Society Chemical Communications. 507–507.

Maxwell, R.A., et al.. (1977). Influence of Desipramine on the Uptake and Efflux of Radiolabelled Bretylium and Bethanidine in the Adventitial and Media-Intimal Layers of Rabbit Aortic Strips. Journal of Vascular Research. 14(5). 303–317. 2 indexed citations

Namm, Donald H., et al.. (1975). Effects of bretylium on rat cardiac muscle: the electrophysiological effects and its uptake and binding in normal and immunosympathectomized rat hearts.. Journal of Pharmacology and Experimental Therapeutics. 193(1). 194–208. 27 indexed citations

Copp, F. C., et al.. (1972). Two new short-acting non-depolarizing neuromuscular blocking agents. Cellular and Molecular Life Sciences. 28(1). 47–48. 3 indexed citations

Copp, F. C., et al.. (1967). New Peripheral Antagonists of 5-Hydroxytryptamine. Nature. 214(5084). 200–201. 52 indexed citations

10.

Boura, A.L.A., F. C. Copp, & A. F. GREEN. (1962). Amidines as Adrenergic Neurone Blocking Agents. Nature. 195(4847). 1213–1214. 2 indexed citations

11.

Boura, A.L.A., F. C. Copp, A. F. GREEN, et al.. (1961). Adrenergic Neurone-blocking Agents related to Choline 2,6-Xylyl Ether Bromide (TM 10), Bretylium and Guanethidine. Nature. 191(4795). 1312–1313. 31 indexed citations

12.

Burrows, Robert B., et al.. (1960). A New Anthelmintic for Canine Hookworm. Nature. 188(4754). 945–946. 4 indexed citations

13.

Boura, A.L.A., et al.. (1960). Powerful Adrenergic Neurone-blocking Agents related to Choline 2,6-Xylyl Ether Bromide. Nature. 185(4717). 925–926. 9 indexed citations

14.

Boura, A.L.A., F. C. Copp, W. G. Duncombe, A. F. GREEN, & A McCoubrey. (1960). THE SELECTIVE ACCUMULATION OF BRETYLIUM IN SYMPATHETIC GANGLIA AND THEIR POSTGANGLIONIC NERVES. British Journal of Pharmacology and Chemotherapy. 15(2). 265–270. 59 indexed citations

15.

Copp, F. C., et al.. (1958). A new series of anthelmmtics. 181. 183. 3 indexed citations

16.

Copp, F. C., et al.. (1958). A New Series of Anthelmintics. Nature. 181(4603). 183–183. 22 indexed citations

17.

Copp, F. C., et al.. (1957). 296. Nitro-compounds as amœbicides. Part I. Compounds related to 2-di-(2-hydroxyethyl)amino-5-nitropyridine. Journal of the Chemical Society (Resumed). 0(0). 1544–1548. 1 indexed citations

18.

Copp, F. C. & G. M. Timmis. (1955). Potential tumour inhibitors. Esters of 4-di-(2-hydroxyethyl)aminopyridine and quaternary derivatives of 2 : 3-dihydroglyoxalino[1 : 2-a]pyridine. Journal of the Chemical Society (Resumed). 2021–2021. 5 indexed citations

19.

Bushby, S. R. M. & F. C. Copp. (1955). The Antitrichomonal Activity of Amidonitrothiazoles. Journal of Pharmacy and Pharmacology. 7(1). 112–117. 24 indexed citations

20.

Copp, F. C.. (1953). 620. Diacid bases. Part I. Compounds related to 1: 5-diphenyl-pentane-pp′-bis(trialkylammonium) salts as anti-cholinesterases. Journal of the Chemical Society (Resumed). 0(0). 3116–3118. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact